Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025)
Envoy Medical's (COCH) quarterly Cash from Investing Activities came in at -$172000.0 in Q4 2025, down 132.21% year-on-year from $534000.0 in Q4 2024, and down 17100.0% quarter-over-quarter from -$1000.0 in Q2 2025.
Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Envoy Medical has disclosed Cash from Investing Activities across 5 years of filings, most recently posting -$172000.0 for Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at -$172000.0, down 132.21% year-over-year; the trailing twelve-month figure through Dec 2025 was -$179000.0 (up 81.73% YoY), and the FY2025 annual result was -$179000.0, up 81.73% from the prior year.
- Cash from Investing Activities came in at -$172000.0 for Q4 2025 at Envoy Medical, down from -$1000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $534000.0 in Q4 2024 to a low of -$420.0 million in Q1 2021.
- The 5-year median for Cash from Investing Activities is -$60500.0 (2023), against an average of -$30.5 million.
- Peak annual rise in Cash from Investing Activities reached 2642.86% in 2024, while the deepest fall reached 7081.82% in 2024.
- Envoy Medical's Cash from Investing Activities stood at -$5.0 million in 2021, then jumped by 99.18% to -$41000.0 in 2022, then surged by 48.78% to -$21000.0 in 2023, then soared by 2642.86% to $534000.0 in 2024, then tumbled by 132.21% to -$172000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$172000.0 (Q4 2025), -$1000.0 (Q2 2025), and -$6000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Envoy Medical | 44.14 Mn | 18.89 Mn | -274,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172,000.00 |
| Dec 31, 2025 | -172,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -11,000.00 |